NCT03676335View on ClinicalTrials.gov

Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry Eye

PHASE2CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

May 9, 2018

Primary Completion Date

June 30, 2019

Study Completion Date

December 12, 2019

Conditions
Dry Eye
Interventions
DRUG

CsA eye gel

The CsA eye gel of 0.3 g: 0.15 mg, 0.3 g: 0.3 mg

DRUG

CsA for eye emulsion

The CsA for eye emulsion of 0.4 ml: 0.2 mg

DRUG

Hypromellose Eye Drops

Hypromellose Eye Drops of 15ml：75mg, 3 times daily, 1-2 drop

Trial Locations (1)

510060

Ophthalmological Center of Zhongshan University, Guangzhou

All Listed Sponsors
lead

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

INDUSTRY

NCT03676335 - Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry Eye | Biotech Hunter | Biotech Hunter